Edition:
United States

Swedish Orphan Biovitrum AB (publ) (SOBIV.ST)

SOBIV.ST on Stockholm Stock Exchange

125.20SEK
22 Mar 2017
Change (% chg)

0.20kr (+0.16%)
Prev Close
125.00kr
Open
124.00kr
Day's High
125.40kr
Day's Low
122.30kr
Volume
894,249
Avg. Vol
950,069
52-wk High
128.80kr
52-wk Low
89.50kr

Latest Key Developments (Source: Significant Developments)

Sobi CEO sees broad interest in Partner Products platform
Thursday, 16 Feb 2017 02:27am EST 

Swedish Orphan Biovitrum AB CEO Geoffrey McDonough to reporters: says there is broad interest in the platform of the partner products division which sobi is considering selling . says his personal view is it would be premature to pay dividend for 2017 as company still in an active development phase Further company coverage: [SOBIV.ST] (Reporting By Anna Ringstrom) ((Anna.Ringstrom@thomsonreuters.com;)).  Full Article

Sobi Q4 EBITA lags expectations
Thursday, 16 Feb 2017 02:00am EST 

Swedish Orphan Biovitrum : Q4 ebita of sek 210 m (90) . Q4 total revenue of sek 1,292 m (814), an increase of 59 per cent (54 per cent at cer) . Q4 gross margin of 67 per cent (64) . Reuters poll: sobi q4 ebita was seen at sek 271 million, revenues at 1,278 million . says expects revenues for full year 2017 to be in range of sek 5,800 to 6,000 m . says 2017 gross margin is expected to be in range of 66 to 68 per cent .says expects ebita for full year to be in range of sek 1,600 to 1,700 m.  Full Article

Sobi confirms divestment discussions, shares halted
Friday, 3 Feb 2017 08:23am EST 

Swedish Orphan Biovitrum : Says confirms that company is in discussions with a private equity firm regarding a possible sale of its partner products business area excluding Kineret and Orfadin. . Says discussions may or may not lead to an agreement . "We have noted specific information in the market regarding a possible sale of Sobi Partner Products. We confirm that we are in discussions which may or may not lead to an agreement", said Geoffrey McDonough, CEO and President .Trade in the Sobi share was suspended at 13:16 GMT.  Full Article

Sobi's CEO divests a portion of shares
Monday, 8 Aug 2016 12:00pm EDT 

: Swedish Orphan Biovitrum (SOBI) says: . CEO Geoffrey McDonough has divested 300,000 of shares he holds in company. .The sale was made for personal financial reasons. After the transaction, McDonough will hold a total of 347,948 shares in the company..  Full Article

Sobi says to repurchase shares
Friday, 15 Jul 2016 02:30am EDT 

Swedish Orphan Biovitrum Publ AB (SOBI) : Says the board of directors exercises its authorisation for repurchase of shares to secure the company's commitments under the incentive programme . Says repurchase of the class C shares may be effected during the period 15 July - 27 September 2016 .Says the class C shares will, following the repurchase, be converted to common shares.  Full Article

SOBI Q2 EBITA above forecast
Friday, 15 Jul 2016 02:08am EDT 

Swedish Orphan Biovitrum : Q2 total revenue was sek 1,469 mln (764) . Q2 EBITA was sek 550 mln (74) . Q2 revenues include a sek 386 mln one-time credit from biogen triggered by first commercial sales of alprolix . Q2 gross margin was 72 per cent (63) . Outlook 2016 unchanged .Reuters poll: Sobi Q2 EBITA was seen at sek 435 mln, revenues at 1,317 mln.  Full Article

Pharming Group amends Ruconest distribution agreement with Sobi
Thursday, 14 Jul 2016 01:00am EDT 

Pharming Group NV : Pharming amends ruconest distribution agreement with Sobi . Pharming to directly commercialise Ruconest in 21 additional Western European, North African and Middle-Eastern markets .Pharming will expand current small European team of experienced hae marketing and medical affairs specialists.  Full Article

Sobi says CEO divests 230,000 shares
Monday, 16 May 2016 02:41am EDT 

Swedish Orphan Biovitrum (Sobi) : Says CEO Geoffrey McDonough has divested 230,000 of the shares he holds in the company . Says the sale was made in part to pay the estimated US tax due relating to the vesting of the company's 2013 long-term incentive programme, and to prepare to invest in the upcoming 2016 long-term incentive programme should it be approved by the Annual General Meeting later this month .  Full Article

Swedish Orphan Biovitrum says outgoing chairman sells 8 million shares
Wednesday, 4 May 2016 02:00am EDT 

Swedish Orphan Biovitrum publ AB (SOBI):Outgoing chairman Bo Jesper Hansen has sold 8 million shares.Hansen now owns 893,846 shares in SOBI.  Full Article

Swedish Orphan Biovitrum extends manufacturing agreements with Pfizer
Friday, 29 Apr 2016 02:01am EDT 

Swedish Orphan Biovitrum publ AB:Sobi signs manufacturing agreements with Pfizer.The agreement has been extended until Dec 31, 2023.  Full Article

More From Around the Web